Rezultati - Agnes Witkiewicz

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    RB-pathway disruption in breast cancer

    RB-pathway disruption in breast cancer od Adam Ertel, Jeffry L. Dean, Hallgeir Rui, Chengbao Liu, Agnes Witkiewicz, Karen E. Knudsen, Erik S. Knudsen

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

    Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells od Christine L. Hostetter, Lauren A. Licata, Christina L. Costantino, Agnes Witkiewicz, Charles Yeo, Jonathan R. Brody, Judith C. Keen

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    The Cell Fate Determination Factor Dachshund Inhibits Androgen Receptor Signaling and Prostate Cancer Cellular Growth

    The Cell Fate Determination Factor Dachshund Inhibits Androgen Receptor Signaling and Prostate Cancer Cellular Growth od Kongming Wu, Sanjay Katiyar, Agnes Witkiewicz, Anping Li, Peter A. McCue, Liang‐Nian Song, Lifeng Tian, Ming Jin, Richard G. Pestell

    Izdano 2009
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward?

    Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward? od Shayna L. Showalter, Timothy N. Showalter, Agnes Witkiewicz, Robert I. Havens, Eugene P. Kennedy, Tomáš Hucl, Scott E. Kern, Charles J. Yeo, Jonathan R. Brody

    Izdano 2008
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer

    Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer od Lyndsay N. Harris, Fanglei You, Stuart J. Schnitt, Agnes Witkiewicz, Xin Lü, Dennis C. Sgroi, Paula D. Ryan, Steven E. Come, Harold J. Burstein, Beth-Ann Lesnikoski, Madhavi Kamma, Paula N. Friedman, Rebecca Gelman, J. Dirk Iglehart, Eric P. Winer

    Izdano 2007
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: